Probi’s business model is based on revenue from licensing and the sale of raw materials and semi-manufactured products.
Each market has unique characteristics in terms competition, size, pricing, and acceptance of and traditions related to probiotics. Accordingly, a fundamental analysis is completed prior to each new investment. This leads to a unique marketing strategy for each market aimed at optimising profitability and limiting risk.
World-class research, both proprietary and in collaboration with partners, is the basis of Probi’s work. R&D is the foundation of the value-creating process: identification, development and patenting of robust probiotic strains with unique, well-documented health benefits and a unique ability to establish themselves in the gastrointestinal tract.